Danyi Wang
Overview
Explore the profile of Danyi Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
161
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gagne M, Flynn B, Andrew S, Marquez J, Flebbe D, Mychalowych A, et al.
Nat Immunol
. 2024 Sep;
25(10):1913-1927.
PMID: 39227514
A mucosal route of vaccination could prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication at the site of infection and limit transmission. We compared protection against heterologous XBB.1.16 challenge...
2.
Wang D, Wang Y
Life Sci
. 2024 Sep;
356:123031.
PMID: 39226989
Aims: Nonalcoholic steatohepatitis (NASH) is the severe subtype of nonalcoholic fatty diseases (NAFLD) with few options for treatment. Patients with NASH exhibit partial responses to the current therapeutics and adverse...
3.
Wang D, Sun D, Wang X, Peng X, Ji Y, Tang L, et al.
MedComm (2020)
. 2024 Jul;
5(7):e634.
PMID: 38988492
Mitogen-activated protein kinase-activated protein kinase 2 (MK2) emerges as a pivotal target in developing anti-cancer therapies. The limitations of ATP-competitive inhibitors, due to insufficient potency and selectivity, underscore the urgent...
4.
Wang D, Bolleddula J, Coenen-Stass A, Grombacher T, Dong J, Scheuenpflug J, et al.
Pharmacogenomics
. 2024 Mar;
25(4):197-206.
PMID: 38511470
Whole-exome sequencing (WES) is widely used in clinical settings; however, the exploration of its use in pharmacogenomic analysis remains limited. Our study compared the variant callings for 28 core absorption,...
5.
Jain S, Kumar S, Lai L, Linderman S, Malik A, Ellis M, et al.
bioRxiv
. 2024 Feb;
PMID: 38370837
The rapid emergence of divergent SARS-CoV-2 variants has led to an update of the COVID-19 booster vaccine to a monovalent version containing the XBB.1.5 spike. To determine the neutralization breadth...
6.
Wang D, Chahl J
Front Robot AI
. 2024 Jan;
10:1266535.
PMID: 38269072
Image-based heart rate estimation technology offers a contactless approach to healthcare monitoring that could improve the lives of millions of people. In order to comprehensively test or optimize image-based heart...
7.
Wang Z, Zhang B, Ou L, Qiu Q, Wang L, Bylund T, et al.
Vaccines (Basel)
. 2024 Jan;
12(1).
PMID: 38250850
The receptor-binding domain (RBD) of the SARS-CoV-2 spike is a primary target of neutralizing antibodies and a key component of licensed vaccines. Substantial mutations in RBD, however, enable current variants...
8.
Xu Z, Peng X, Zhang R, Ji Y, You M, Wang D, et al.
J Med Chem
. 2024 Jan;
67(2):1168-1183.
PMID: 38227770
Tropomyosin receptor kinase (TRK) fusion, an oncogenic form of kinase with pan-tumor occurrence, is a clinically validated important antitumor target. In this study, we screened our in-house kinase inhibitor library...
9.
Gorman J, Cheung C, Duan Z, Ou L, Wang M, Chen X, et al.
Nat Commun
. 2024 Jan;
15(1):285.
PMID: 38177144
Lassa virus (LASV) infection is expanding outside its traditionally endemic areas in West Africa, posing a pandemic biothreat. LASV-neutralizing antibodies, moreover, have proven difficult to elicit. To gain insight into...
10.
Fang F, Dai Y, Wang H, Ji Y, Liang X, Peng X, et al.
Acta Pharm Sin B
. 2023 Dec;
13(12):4918-4933.
PMID: 38045061
As a novel and promising antitumor target, AXL plays an important role in tumor growth, metastasis, immunosuppression and drug resistance of various malignancies, which has attracted extensive research interest in...